Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00050622 · ClinicalTrials.gov registry record · NA

Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)

A NA study of Attention Deficit Disorder With Hyperactivity, sponsored by Florida International University.

Completed
Registry status
NA
Development phase
154
Enrollment target
2
Study locations

NCT00050622 is a NA study of Attention Deficit Disorder With Hyperactivity that has completed, run by Florida International University. The registered enrollment target is 154 participants, below the 347-participant average among 20 other Attention Deficit Disorder With Hyperactivity trials with a reported enrollment target (56% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00050622, a NA study of Attention Deficit Disorder With Hyperactivity, has completed, sponsored by Florida International University.

COMPLETED
Registry status
NA
Development phase
154 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to determine the effectiveness of behavioral treatment, drug treatment, and combined treatment for children with Attention Deficit Hyperactivity Disorder (ADHD). This study will also examine the interactions between different levels of behavioral and drug treatments.

Conditions Studied

Attention Deficit Disorder With Hyperactivity

Interventions

  • DRUG Placebo
  • DRUG Methylphenidate 0.15 mg/kg
  • BEHAVIORAL Low-Intensity BMOD
  • DRUG Methylphenidate 0.3 mg/kg
  • DRUG Methylphenidate 0.6 mg/kg

Study Locations (2)

Florida

  • Florida International University Center for Children and Families - Miami

New York

  • Center for Children and Families, University at Buffalo - Buffalo

Trial Details

FieldValue
Enrollment Target 154 participants
Start Date 2001-09
Est. Completion 2005-06
Phase NA

Sponsor

Florida International University

89 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00050622

The ClinicalTrials.gov registry entry for NCT00050622 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 347-participant average among 20 other Attention Deficit Disorder With Hyperactivity trials with a reported enrollment target (56% lower). The listed sponsor is Florida International University, which has 89 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Attention Deficit Disorder With Hyperactivity appearing as the primary indexed condition, and to 5 interventions - of which Placebo is the first listed.

NCT00050622 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, New York.

Frequently Asked Questions

What is clinical trial NCT00050622 about?

NCT00050622 is a clinical study titled "Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)". The purpose of this study is to determine the effectiveness of behavioral treatment, drug treatment, and combined treatment for children with Attention Deficit Hyperactivity Disorder (ADHD). This study will also examine the interactions between different levels of behavioral and drug treatments.

What is the current status of trial NCT00050622?

This trial is currently completed. It is a NA study. The enrollment target is 154 participants. The study started on 2001-09. Estimated completion is 2005-06.

What conditions does trial NCT00050622 study?

This clinical trial studies the following conditions: Attention Deficit Disorder With Hyperactivity.

What interventions are being tested in trial NCT00050622?

The interventions under investigation include: Placebo (DRUG), Methylphenidate 0.15 mg/kg (DRUG), Low-Intensity BMOD (BEHAVIORAL), Methylphenidate 0.3 mg/kg (DRUG), Methylphenidate 0.6 mg/kg (DRUG).

Who is sponsoring clinical trial NCT00050622?

This trial is sponsored by Florida International University, which has 89 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00050622 being conducted?

This trial has 2 study locations across Florida, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Attention Deficit Disorder With Hyperactivity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Attention Deficit Disorder With Hyperactivity

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.